L679-0122 Screening compound: methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate

L679-0122 Screening compound: methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate
L679-0122 Screening compound: methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L679-0122
methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L679-0122

Molecular Formula

C28H30N6O3 (C28 H30 N6 O3)

Compound Name

methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate

IUPAC name

methyl 2-[(4-{[3-(4-ethylphenyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}piperazine-1-carbonyl)amino]benzoate

SMILES

CCc(cc1)ccc1-n1c(nccc2)c2nc1CN(CC1)CCN1C(Nc(cccc1)c1C(OC)=O)=O

InChI

InChI=1S/C28H30N6O3/c1-3-20-10-12-21(13-11-20)34-25(30-24-9-6-14-29-26(24)34)19-32-15-17-33(18-16-32)28(36)31-23-8-5-4-7-22(23)27(35)37-2/h4-14H,3,15-19H2,1-2H3,(H,31,36)

InChI Key

KRGFUCZYHRKYMT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27468989

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.077

Distribution Coefficient, logD

4.073

Water Solubility, LogSw

-4.04

Polar Surface Area

71.279

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

5.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

L679-0122 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Epigenetics Focused Set (26518 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
  • Ion Channels
  • Kinases
  • Ion Channels

References: we are preparing a list of scientific research reports with L679-0122 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L679-0122?
Check Price and Availability of L679-0122, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L679-0122 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L679-0122
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L679-0122
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L679-0122 available by request